⌘K

Home/Filings/4/0001144204-17-004355

4//SEC Filing

Caladrius Biosciences, Inc. 4

Accession 0001144204-17-004355

$LSTACIK 0000320017operating

View on SEC.gov Company Profile

Filed

Jan 26, 7:00 PM ET

Accepted

Jan 27, 5:00 PM ET

Size

5.1 KB

Accession

0001144204-17-004355

Insider Transaction Report

Form 4

Period: 2017-01-25

Caladrius Biosciences, Inc.CLBS

LOSORDO DOUGLAS W

Chief Medical Officer

Transactions

Tax Payment
Common Stock
2017-01-25$3.87/sh−249$964→ 26,164 total

Footnotes (1)

[F1]Includes 13,771 shares of unvested restricted stock.

Documents

1 file

4
v457627_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Caladrius Biosciences, Inc.

CIK 0000320017

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000320017

Filing Metadata

Form type: 4
Filed: Jan 26, 7:00 PM ET
Accepted: Jan 27, 5:00 PM ET
Size: 5.1 KB

View on SEC.gov